Apyx Medical Corporation (APYX) vs Foghorn Therapeutics Inc. (FHTX)
A side-by-side comparison of Apyx Medical Corporation and Foghorn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APYX
Apyx Medical Corporation
$2.60HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
FHTX
Foghorn Therapeutics Inc.
$2.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — APYX vs FHTX
growth of $100 · dividends reinvested · last 6yAPYX -58.1% (-13.5%/yr)FHTX -89.0% (-30.7%/yr)APYX compounded faster over this window
APYX FHTX
APYX vs FHTX: by the numbers
- •FHTX is the larger company ($117M vs $109M market cap).
- •Both run net losses; APYX's is the smaller (-14.78% vs -175.78% net margin).
- •FHTX grew revenue faster over the past five years (105.83% vs 8.82% CAGR).
Metrics side by side
Valuation
| Metric | APYX | FHTX |
|---|---|---|
| P/S ratio | 1.87 | 3.20 |
| P/B ratio | 10.27 | N/A |
Profitability
| Metric | APYX | FHTX |
|---|---|---|
| Gross margin | 33.94% | 89.22% |
| Operating margin | -6.06% | -265.64% |
| Net margin | -14.78% | -175.78% |
| ROE | -80.97% | N/A |
| ROIC | -6.84% | -44.81% |
Growth (annualized)
| Metric | APYX | FHTX |
|---|---|---|
| Revenue CAGR (5Y) | 8.82% | 105.83% |
| Total return CAGR (5Y) | -28.10% | -31.87% |
Frequently asked
- Which has grown faster, APYX or FHTX?
- Over the past five years, FHTX grew revenue faster — APYX at a 8.82% CAGR versus FHTX at 105.83%.
- How have APYX and FHTX total returns compared?
- Over the past 5 years, APYX delivered -28.10% and FHTX delivered -31.87% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Apyx Medical ROEFoghorn Therapeutics ROEApyx Medical operating marginFoghorn Therapeutics operating marginApyx Medical revenue growthFoghorn Therapeutics revenue growthApyx Medical free cash flowFoghorn Therapeutics free cash flow
Apyx Medical & Foghorn Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.